Exscientia
Founded in 2012, Exscientia is the leading pharmatech company and the first to automate drug discovery. As a full stack AI drug discovery company, Exscientia generates its own data before combining the analytical power of AI with the creativity and expertise of world-class scientists. This allows Exscientia to shorten the pre-clinical drug discovery stage by at least three-quarters and, in turn, substantially accelerate the delivery of new treatments to patients worldwide.
Oxford Nanopore
Oxford Nanopore Technologies has developed the world’s first and only nanopore DNA sequencer, the MinION. The MinION is a portable, real time, long-read, low cost device that has been designed to bring easy biological analyses to anyone, whether in scientific research, education or a range of real world applications such as disease/pathogen surveillance, environmental monitoring, food chain surveillance, self-quantification or even microgravity biology. Commercially available since 2015, the MinION is in use by a thriving community in more than 50 countries, enabling myriad applications within the traditional laboratory environment and in the field.